CAM
PSTX

Crown Advisors Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Crown Advisors Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-150,000
Closed -$462K – 56
2023
Q1 		$462K Hold
150,000
– – 0.34% 48
2022
Q4 		$795K Hold
150,000
– – 0.72% 40
2022
Q3 		$529K Buy
+150,000
New +$529K 0.53% 41